typically in preteens aged 11–12, though it can be given up to age 45. The vaccine stimulates the immune system to develop long-lasting protection against high-risk HPV strains. Safe and ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

At just 12 years old, Juliana recently attended a cervical cancer summit and is now leading the way to help raise awareness ...

This is why it is recommended for preteens aged 11-12. #3 Myth ... transmitted infections (STIs). The HPV vaccine specifically protects against certain strains of the HPV virus.